Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive steep apnea

被引:22
作者
Baldwin, CM
Bootzin, RR
Schwenke, DC
Quan, SF
机构
[1] Arizona State Univ, Coll Nursing, Tempe, AZ 85287 USA
[2] Carl T Hayden VA Med Ctr, Phoenix, AZ 85012 USA
[3] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA
[4] Arizona State Univ, WP Carey Sch Hlth Management & Policy, Tempe, AZ USA
[5] Sleep & Arizona Resp Ctr, Tucson, AZ 85724 USA
关键词
alpha-lipoic acid; antioxidants; cardiovascular disease; coenzyme Q(10); cognitive deficits; Cytokines; homocysteine; nutrient intake; obstructive sleep apnea; oxidative stress;
D O I
10.1016/j.smrv.2005.04.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive deficits and cardiovascular disease (CVD) are comorbid conditions frequently associated with obstructive steep apnea (OSA). Oxygen free radical release and its differential regulation of cytokine synthesis and immune modulation resulting from OSA-related hypoxic events have been hypothesized as the underlying mechanism(s) for the cognitive deficits and CVD in OSA. A number of studies have suggested that increased levels of oxidative stress and/or antioxidant deficiencies may also be risk factors in cognitive decline and CVD. The influence of antioxidant nutrients and supplements, such as Vitamins B6, B12, C, E, folic acid, alpha-lipoic acid and Coenzyme Q(10) on cognitive decline and CVD have been investigated. The influence of antioxidant nutrients or supplements on OSA remains to be investigated. Even if dietary or supplemental antioxidants do not prove to be effective therapies for OSA, dietary assessment and prescription to increase dietary intake of neuro- and cardio-protective nutrients may make it possible to reduce some of the cognitive and cardiovascular sequelae associated with OSA. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:459 / 476
页数:18
相关论文
共 129 条
[91]   Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers [J].
Pellegrini, MP ;
Newby, DE ;
Johnston, NR ;
Maxwell, S ;
Webb, DJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (01) :117-124
[92]   C-reactive protein: a critical update [J].
Pepys, MB ;
Hirschfield, GM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1805-1812
[93]   Vitamin C exhibits pro-oxidant properties [J].
Podmore, ID ;
Griffiths, HR ;
Herbert, KE ;
Mistry, N ;
Mistry, P ;
Lunec, J .
NATURE, 1998, 392 (6676) :559-559
[94]  
Quadri P, 2004, AM J CLIN NUTR, V80, P114
[95]  
Rackley Charles E, 2004, Cardiol Rev, V12, P151, DOI 10.1097/01.crd.0000126083.86717.5b
[96]   High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention [J].
Ridker, PM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4B) :17K-22K
[97]   Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials [J].
Robinson, GV ;
Pepperell, JCT ;
Segal, HC ;
Davies, RJO ;
Stradling, JR .
THORAX, 2004, 59 (09) :777-782
[98]  
Roitt I., 2002, Immunology, V5
[99]   Insulin resistance in adipose tissue:: direct and indirect effects of tumor necrosis factor-α [J].
Ruan, H ;
Lodish, HF .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (05) :447-455
[100]   Does lack of tocopherols and tocotrienols put women at increased risk of breast cancer? [J].
Schwenke, DC .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2002, 13 (01) :2-20